Medicines for Infusion and Injection
Original notice title
Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection
Opportunity Score
Why this score?
Opportunity
54 / 100
Complexity
60 / 100
Risk factors
The available data does not include the detailed procurement documents, product specifications, pricing templates, fram...
No estimated value or framework maximum value is disclosed, making pricing strategy, capacity planning, and expected op...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- SYKEHUSINNKJØP HF
- Country
- Norway
- CPV
- 33000000 - Medical equipments, pharmaceuticals and personal care products +1 more
- Deadline
- Sep 17, 2026
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jan 2030
- Supply of various medicines for use in infusion injections.
- Performance location: Norway.
Show full summary
Open procedure for a framework agreement covering various medicines for infusion injections in Norway. The structured data identifies one lot, mandatory electronic submission, Norwegian language, and a submission deadline of 17 September 2026 at 10:00. Procurement documents appear available through the Ivalua portal, but the underlying procurement documents were not provided or analyzed. Contract value, selection criteria, and award criteria are missing. The structured data also conflicts with the XML notice on EU funding status.
Risks
The available data does not include the detailed procurement documents, product specifications, pricing templates, fram...
No estimated value or framework maximum value is disclosed, making pricing strategy, capacity planning, and expected op...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Open procedure.
- Supply contract for medicinal products.
Administrative
- Electronic submission is required through the specified Ivalua portal.
Award Criteria
Lot 1
Buyer
Location
VADSØ, NOR
Buyer profile
Identifier
916879067
Activity
Health
Lots (1)
LOT-0001
Medicines for Infusion and Injection
Supply of various medicines intended for use in infusion injections in Norway. The lot is identified as a framework agreement with a planned period from 1 February 2028 to 31 January 2030. Detailed product requirements and commercial conditions are not available in the provided data.
Location
Duration
Category
Award Criteria
Deadline
Award details
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Additional CPV codes
Value note
Show original TED data
Original lot title
2801c Medicines infusion injection
Original TED description
Sykehusinnkjøp HF, division Pharmaceuticals, shall procure various medicines for use in infusion injections. The contracting authorities for this competition are the four regional health authorities in Norway, Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF.
Procurement Details
- Publication date
- 23 Jun 2026
- Languages
- English, Norwegian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 431517-2026
Documents (1)
Similar tenders
Spain – Various medicinal products – Suministro de medicamentos destinado a terapias genicas mediante SDA
Italy – Various medicinal products – Bando V SDA farmaci
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на КОЦ-Русе ЕООД
Italy – Various medicinal products – ARIA_2025_045
Bulgaria – Pharmaceutical products – Доставка на лекарствени продукти за нуждите на УМБАЛ "Царица Йоанна-ИСУЛ" ЕАД
Italy – Various medicinal products – Bando SDA Farmaci, Emoderivati, Vaccini e Mezzi di contrasto - Terza edizione
Opportunity Score
Why this score?
Opportunity
54 / 100
Complexity
60 / 100
Risk factors
The available data does not include the detailed procurement documents, product specifications, pricing templates, fram...
No estimated value or framework maximum value is disclosed, making pricing strategy, capacity planning, and expected op...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications